The ophthalmic market is rapidly evolving, driven by increasing demand for preservative-free formulations, patient-friendly delivery systems, enhanced drug bioavailability, and stringent global quality standards. At Akums, we combine scientific expertise, advanced sterile manufacturing technologies, and proprietary formulation platforms to help pharmaceutical companies develop differentiated ophthalmic products with confidence.
Our dedicated Ophthalmic Manufacturing Facility has been designed to manufacture a comprehensive range of sterile eye care products under highly controlled aseptic conditions. Supported by robust quality systems, advanced engineering, and regulatory expertise, the facility enables seamless transition from product development to commercial manufacturing while maintaining the highest standards of sterility, safety, and product performance.
Whether you are developing a novel ophthalmic therapy, expanding an existing product portfolio, or seeking a trusted CDMO partner, Akums delivers integrated solutions that accelerate product development and market access.
Our manufacturing capabilities span multiple ophthalmic dosage forms and advanced drug delivery systems, enabling customers to address diverse therapeutic and commercial requirements.
Designed for high-speed, high-volume sterile manufacturing, our Form-Fill-Seal technology integrates container formation, aseptic filling, and sealing into a single continuous process. This minimizes human intervention, reduces contamination risk, and enhances manufacturing efficiency.
Key AdvantagesOur UNIMS® technology provides convenient single-use ophthalmic packaging designed to improve patient safety and dosing accuracy. The unit-dose presentation eliminates repeated exposure to external contaminants while delivering the precise quantity of medication required for each application.
BenefitsGrowing clinical preference for preservative-free ophthalmic products has increased demand for specialized manufacturing capabilities.
Our facility supports sterile manufacturing of preservative-free ophthalmic formulations that improve ocular comfort while reducing preservative-related toxicity and irritation associated with long-term therapy.
These products are particularly suitable for chronic ophthalmic treatments and patients with sensitive eyes.
Akums manufactures conventional multidose ophthalmic solutions and suspensions using advanced aseptic filling technologies and high-quality packaging systems. These dosage forms offer flexibility across multiple therapeutic categories while ensuring product stability, dosing convenience, and regulatory compliance.
Suitable for:Innovation is central to our ophthalmic development strategy. Our proprietary formulation technologies enable pharmaceutical companies to overcome formulation challenges while improving product differentiation and patient outcomes.
PRIBSYS™ is an advanced ionic-buffered preservative technology that eliminates the need for Benzalkonium Chloride (BKC)—one of the most widely used preservatives in ophthalmic formulations. By replacing conventional preservative systems, PRIBSYS™ enhances ocular tolerability while minimizing preservative-induced irritation and toxicity.
Technology BenefitsMany ophthalmic APIs possess poor aqueous solubility, making suspension formulations the conventional choice. e-Sol™ technology enables the conversion of ophthalmic suspensions into elegant, clear solutions, improving patient experience while enhancing therapeutic performance.
Key AdvantagesAqua Nano Micellar™ technology utilizes nano-sized micelles to encapsulate poorly soluble active pharmaceutical ingredients, enabling their effective dispersion within aqueous ophthalmic formulations. This innovative approach improves formulation stability while enhancing drug delivery and patient experience.
Platform BenefitsEvery ophthalmic product is manufactured within highly controlled sterile environments designed to ensure product quality, sterility, and regulatory compliance.
The facility integrates advanced engineering systems with validated aseptic manufacturing processes to deliver consistent, high-quality ophthalmic formulations.
Water for Injection (WFI)-based manufacturing systems
Aseptic filling under Laminar Air Flow (LAF)
Validated double sterile filtration systems
Automated Cleaning-In-Place (CIP) systems
Automated Sterilization-In-Place (SIP) systems
Controlled cleanroom manufacturing environments
Sterile primary packaging components
Validated environmental monitoring systems
Integrated contamination control strategy
Quality is embedded throughout the product lifecycle—from formulation development and raw material qualification to commercial manufacturing and final product release. Our quality systems ensure every batch consistently meets predefined specifications for sterility, safety, efficacy, and regulatory compliance.
Beyond manufacturing, Akums serves as an integrated development partner for ophthalmic products. Our multidisciplinary teams support customers throughout the product lifecycle, enabling faster development timelines and smoother regulatory pathways.
Every ophthalmic program is unique. Our collaborative development model enables flexible engagement tailored to the technical, regulatory, and commercial requirements of each partner.
We work closely with customers to deliver solutions that accelerate development while ensuring quality and manufacturing excellence.
At Akums, we are committed to advancing ophthalmic healthcare through innovation, scientific excellence, and uncompromising quality. Every formulation manufactured at our ophthalmic facility reflects our focus on patient safety, regulatory compliance, technological advancement, and manufacturing precision. From concept to commercialization, we empower our partners with reliable manufacturing solutions that support successful product launches across domestic and international markets.
Modern ophthalmic therapies demand more than sterility—they require enhanced patient comfort, improved drug delivery, preservative-free solutions, and differentiated formulations that improve treatment outcomes.
By combining proprietary technology platforms with advanced sterile manufacturing capabilities, Akums helps pharmaceutical companies create next-generation ophthalmic products that address these evolving healthcare needs.
Whether you're developing preservative-free eye drops, advanced ophthalmic solutions, unit-dose therapies, or novel ocular drug delivery systems, Akums offers the scientific expertise, sterile manufacturing infrastructure, and global regulatory capabilities to help bring your vision to life.
Partner with Akums to elevate your pharmaceutical, nutraceutical, and cosmetic supply chain. As India's leading CDMO, we offer end-to-end solutions, including R&D, formulation development, and large-scale manufacturing. Our state-of-the-art facilities comply with stringent global standards, ensuring product safety, efficacy, and quality. With a strong focus on innovation, we deliver tailored solutions to meet your unique business needs. Whether you're launching a new product or enhancing your current supply chain, Akums provides reliable expertise, seamless scalability, and unwavering commitment to excellence. Join hands with Akums to strengthen your brand and achieve sustained growth in competitive markets.